EHMT2 and neoplasm: Indeed, G9a expression levels significantly associate with poor clinical outcomes, but also correlate with pluripotent transcriptional signature, which was recently demonstrated as a robust indicator of tumor aggressiveness and neoplastic stem cell phenotype [6].